Annals Internal Medicine, AstraZeneca, Author Interviews, Brigham & Women's - Harvard, Heart Disease, Merck, Pharmacology / 25.07.2017
Trying Statins Again After Adverse Effect Linked To Lower Risk of Heart Attack
MedicalResearch.com Interview with:
Alexander Turchin, MD,MS
Director of Quality in Diabetes
Associate Professor, Harvard Medical School
Brigham and Women's Hospital
Boston, MA
MedicalResearch.com: What is the background for this study?
Response: Cardiovascular disease is the # 1 cause of death in the U.S. and worldwide. Statins are some of the most effective medications available for prevention of cardiovascular events.
However, many patients stop statins, frequently because of adverse reactions. In our study we aimed to assess the risk-benefit balance of trying a statin again after experiencing an adverse reaction.
(more…)